Added to YB: 2024-08-20
Pitch date: 2024-08-17
CLPT [bullish]
ClearPoint Neuro, Inc.
+7.93%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$365.6M
Pitch Price
$10.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
-17.88
P/E
-12.07
EV/Sales
9.69
Sector
Health Care Equipment and Supplies
Category
growth
ClearPoint Neuro's Strategic Expansion: A Medtech Powerhouse in the Making
CLPT: Biotech ETF wrapped in medtech platform. Q2 shows inflection: 76% stock run, improved margins, reduced burn. On track to exceed 100 sites by 2025. New OR & LITT systems, biologics growth (7 FDA fast-tracked), royalty deals. Underrated: CGMP facility, data moat, strategic pharma partner. Cash flow breakeven expected Q4 2025.
Read full article (3 min)